NeuBase Therapeutics Inc at Jefferies Healthcare Conference Transcript
Hello, and welcome to the Jefferies 2022 Healthcare Conference. It's my great honor to introduce Todd Branning, CFO of NeuBase Therapeutics. Thank you so much.
Good morning, everyone, and thank you so much for hosting us today here at the conference. We're pleased to be here. I am subbing for our CEO today, Dietrich Stephan. He was unfortunately unavailable to make it this morning. So I'll be doing the presentation, but hopefully, we'll be able to cover all the details that Dietrich would have covered if he were here.
So I'll start out by saying that we acknowledge that NeuBase is -- it's difficult to get some attention on a company like NeuBase in this environment that we're in right now. We are a small preclinical company at this phase of our existence. But we accept that as our current reality and know that there are going to be companies like us that do, over time, generate what we believe will be successful performance, and we believe NeuBase will be one of the one of those companies.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
